News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
778,324 Results
Type
Article (74316)
Company Profile (511)
Press Release (703497)
Section
Business (211979)
Career Advice (3743)
Deals (38016)
Drug Delivery (119)
Drug Development (88294)
Employer Resources (191)
FDA (17652)
Job Trends (16436)
News (368059)
Policy (36779)
Tag
Academia (2964)
Alliances (53564)
Alzheimer's disease (1395)
Approvals (17585)
Artificial intelligence (192)
Bankruptcy (372)
Best Places to Work (12489)
Biotechnology (375)
Breast cancer (218)
Cancer (1632)
Cardiovascular disease (141)
Career advice (3181)
CAR-T (124)
Cell therapy (354)
Clinical research (70315)
Collaboration (614)
Compensation (318)
COVID-19 (2811)
C-suite (147)
Data (1509)
Diabetes (205)
Diagnostics (6690)
Earnings (80627)
Employer resources (166)
Events (122249)
Executive appointments (501)
FDA (18460)
Funding (547)
Gene therapy (248)
GLP-1 (738)
Government (5007)
Healthcare (20607)
Infectious disease (2917)
Inflammatory bowel disease (129)
Interviews (731)
IPO (17345)
Job creations (4420)
Job search strategy (2601)
Layoffs (497)
Legal (8749)
Lung cancer (246)
Manufacturing (241)
Medical device (14239)
Medtech (14244)
Mergers & acquisitions (20930)
Metabolic disorders (565)
Neuroscience (1797)
NextGen: Class of 2025 (7493)
Non-profit (5055)
Northern California (1903)
Obesity (324)
Opinion (253)
Patents (142)
People (62546)
Phase I (21854)
Phase II (30667)
Phase III (22999)
Pipeline (636)
Postmarket research (3144)
Preclinical (9672)
Radiopharmaceuticals (261)
Rare diseases (318)
Real estate (6787)
Regulatory (24743)
Research institute (2629)
Resumes & cover letters (594)
Southern California (1657)
Startups (3977)
United States (17530)
Vaccines (674)
Weight loss (248)
Date
Today (38)
Last 7 days (417)
Last 30 days (1994)
Last 365 days (37099)
2025 (1735)
2024 (37558)
2023 (42272)
2022 (53546)
2021 (58398)
2020 (57257)
2019 (50933)
2018 (38764)
2017 (36083)
2016 (36465)
2015 (42336)
2014 (36195)
2013 (32307)
2012 (34192)
2011 (34428)
2010 (33891)
Location
Africa (1118)
Arizona (208)
Asia (45949)
Australia (8072)
California (4396)
Canada (1566)
China (380)
Colorado (197)
Connecticut (222)
Europe (105054)
Florida (612)
Georgia (153)
Illinois (481)
Indiana (254)
Maryland (730)
Massachusetts (3486)
Michigan (205)
Minnesota (331)
New Jersey (1234)
New York (1238)
North Carolina (904)
Northern California (1903)
Ohio (161)
Pennsylvania (1018)
South America (1504)
Southern California (1657)
Texas (636)
Utah (127)
Washington State (457)
778,324 Results for "american association for the advancement of science".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Idorsia is advancing the treatment of hypertension with new data at the 2024 American Heart Association (AHA) Scientific Sessions
November 12, 2024
·
5 min read
Theralase(R) to Host Advisory Board Meetings at Canadian Urological Association Bladder Cancer Forum and the American Urological Association
Theralase® Technologies Inc. announced that it is hosting Advisory Board meetings to present the latest Study II interim clinical data to its Principal Investigators at the Canadian Urological Association Bladder Cancer Forum and the American Urology Association, respectively.
March 26, 2024
·
5 min read
Press Releases
Cardiol Therapeutics’ Phase II MAvERIC-Pilot Clinical Results in Recurrent Pericarditis Presented at the American Heart Association Scientific Sessions 2024
Marked and rapid reductions in both pericarditis pain and inflammation maintained throughout the 26-week study Episodes of pericarditis per year substantially reduced MAvERIC-Pilot results support advancing CardiolRx™ into the Phase II/III MAVERIC-2 and the Phase III MAVERIC-3 clinical trials
November 18, 2024
·
11 min read
Press Releases
American Brain Tumor Association Names New President & Chief Executive Officer
November 19, 2024
·
3 min read
Press Releases
Rocket Pharmaceuticals to Present Updated Data from the Phase 1 Clinical Trial of RP-A501 for Danon Disease at the American Heart Association’s 2024 Late-Breaking Science Sessions
November 12, 2024
·
7 min read
Press Releases
American Brain Tumor Association Awards Over $1 Million in New Grants to Advance Brain Cancer Research
October 23, 2024
·
4 min read
FDA
Association for Diagnostics & Laboratory Medicine (formerly AACC) files an amicus brief backing the American Clinical Laboratory Association’s lawsuit against the FDA
October 7, 2024
·
5 min read
Biotech Bay
Corcept Announces Presentation of Results From Prevalence Phase of CATALYST Clinical Trial at American Diabetes Association’s Scientific Sessions
Corcept Therapeutics Incorporated (NASDAQ: CORT) today announced that results from the prevalence phase of its CATALYST study of hypercortisolism (Cushing’s syndrome) in patients with difficult-to-control type 2 diabetes were presented at the American Diabetes Association’s 84th Scientific Sessions.
June 24, 2024
·
5 min read
Press Releases
Galectin Therapeutics Presents Three Abstracts at the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting
November 18, 2024
·
4 min read
Drug Development
Viking Therapeutics Presents Preclinical Data on Novel Dual Amylin and Calcitonin Receptor Agonists at 84th Scientific Sessions of the American Diabetes Association
Viking Therapeutics, Inc. today announced the presentation of preclinical data from a series of internally developed dual agonists of the amylin and calcitonin receptors at the 84th Scientific Sessions of the American Diabetes Association.
June 24, 2024
·
6 min read
1 of 77,833
Next
